Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Geriatric Medicines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Geriatric Medicinesmarket, defines the market attractiveness level of Geriatric Medicines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Geriatric Medicines industry, describes the types of Geriatric Medicines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Geriatric Medicines market and the development prospects and opportunities of Geriatric Medicines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Geriatric Medicines market in Chapter 13.
By Player:
AstraZeneca
Novartis
Merck
Bristol-Myers Squibb
Pfizer
Eli Lilly and Company
GSK
Abbott Laboratories
Boehringer Ingelheim
Sanofi
By Type:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
By End-User:
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Geriatric Medicines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Geriatric Medicines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Geriatric Medicines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Geriatric Medicines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Geriatric Medicines Market Analysis and Outlook to 2022
-
7.1 Global Geriatric Medicines Consumption (2017-2022)
-
7.2 United States Geriatric Medicines Consumption (2017-2022)
-
7.3 Europe Geriatric Medicines Consumption (2017-2022)
-
7.4 China Geriatric Medicines Consumption (2017-2022)
-
7.5 Japan Geriatric Medicines Consumption (2017-2022)
-
7.6 India Geriatric Medicines Consumption (2017-2022)
-
7.7 South Korea Geriatric Medicines Consumption (2017-2022)
8 Region and Country-wise Geriatric Medicines Market Analysis and Outlook to 2028
-
8.1 Global Geriatric Medicines Consumption Forecast (2022-2028)
-
8.2 United States Geriatric Medicines Consumption Forecast (2022-2028)
-
8.3 Europe Geriatric Medicines Consumption Forecast (2022-2028)
-
8.4 China Geriatric Medicines Consumption Forecast (2022-2028)
-
8.5 Japan Geriatric Medicines Consumption Forecast (2022-2028)
-
8.6 India Geriatric Medicines Consumption Forecast (2022-2028)
-
8.7 South Korea Geriatric Medicines Consumption Forecast (2022-2028)
9 Global Geriatric Medicines Market Outlook by Types and Applications to 2022
-
9.1 Global Geriatric Medicines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antihypertensives Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Statins Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antidiabetics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Proton Pump Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Anticoagulant Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Antidepressants Consumption and Growth Rate (2017-2022)
-
9.2 Global Geriatric Medicines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cardiovascular diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Osteoporosis Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Respiratory Consumption and Growth Rate (2017-2022)
10 Global Geriatric Medicines Market Outlook by Types and Applications to 2028
-
10.1 Global Geriatric Medicines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antihypertensives Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Proton Pump Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Anticoagulant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Geriatric Medicines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cardiovascular diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
11 Global Geriatric Medicines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Geriatric Medicines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Geriatric Medicines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Geriatric Medicines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Geriatric Medicines Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Geriatric Medicines Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Geriatric Medicines Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Geriatric Medicines Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Geriatric Medicines Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Geriatric Medicines Product and Service
-
14.6 Eli Lilly and Company
-
14.6.1 Eli Lilly and Company Company Details
-
14.6.2 Eli Lilly and Company Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly and Company Geriatric Medicines Product and Service
-
14.7 GSK
-
14.7.1 GSK Company Details
-
14.7.2 GSK Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GSK Geriatric Medicines Product and Service
-
14.8 Abbott Laboratories
-
14.8.1 Abbott Laboratories Company Details
-
14.8.2 Abbott Laboratories Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abbott Laboratories Geriatric Medicines Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Geriatric Medicines Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Geriatric Medicines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Geriatric Medicines
-
Figure Geriatric Medicines Picture
-
Table Global Geriatric Medicines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Geriatric Medicines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Geriatric Medicines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Geriatric Medicines Consumption by Country (2017-2022)
-
Figure United States Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Table Europe Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Figure China Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Figure Japan Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Figure India Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Geriatric Medicines Consumption and Growth Rate (2017-2022)
-
Figure Global Geriatric Medicines Consumption Forecast by Country (2022-2028)
-
Figure United States Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Geriatric Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Antihypertensives Consumption and Growth Rate (2017-2022)
-
Figure Global Statins Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure Global Proton Pump Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Anticoagulant Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoporosis Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antihypertensives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Statins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Proton Pump Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticoagulant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Geriatric Medicines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Geriatric Medicines Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Geriatric Medicines Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Geriatric Medicines Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Geriatric Medicines Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Geriatric Medicines Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Geriatric Medicines Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Geriatric Medicines Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Geriatric Medicines Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Geriatric Medicines Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Geriatric Medicines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Geriatric Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Geriatric Medicines Product and Service
-
